Pfizer/King
Transaction details
The Competition Authority has cleared the proposed transaction whereby Pfizer Incorporated would acquire sole control of King Pharmaceuticals Incorporated.
Case details
- Notification date:28 October 2010
- Publication date:28 October 2010
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacture of pharmaceuticals - C.21
- Outcome:Cleared
Documents
M.10.037 Merger AnnouncementPDF | 42 KBM.10.037 Merger Announcement PDF | 42 KB - Opens in new window
M.10.037 DeterminationPDF | 72 KBM.10.037 Determination PDF | 72 KB - Opens in new window
Timetable
Parties Involved
Pfizer Inc.
Pfizer is a global research-based biomedical and pharmaceutical company active in discovering, developing, manufacturing, marketing and selling innovative medicines for humans and animals.
King Pharmaceuticals Inc.
King is a pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in speciality-driven markets including neuroscience, hospital and acute care medicines.
Contacts
